We have a new and exciting opportunity for a Postdoctoral Researcher in Radiopharmacy and Molecular Imaging Group, led by Dr Bart Cornelissen. The aim of the Group is the development of novel preclinical imaging agents for oncology. For more information please visit: www.rob.ox.ac.uk/research/bart-cornelissen. The project will be performed in collaboration with Professor Marion De Jong and Dr Julie Nonnekens at MC Erasmus Rotterdam, the Netherlands, Dr Samantha Terry at King’s College London, and Professor Katherine Vallis and Dr Nadia Falzone at the CRUK/MRC Oxford Institute for Radiation Oncology. The research will be mainly based in Oxford, but will involve work in Rotterdam and London.As part of the role, you will undertake research into the imaging of DNA damage in vitro and in vivo using SPECT and PET imaging after Peptide Radionuclide Radiotherapy (PRRT). The project involves the application and combination of imaging and radionuclide therapy agents developed in our groups, to improve the treatment of neuroendocrine tumours, especially those in the pancreas.You will hold, or will be working towards, a PhD in chemistry, biochemistry, molecular biology or a related science, with a strong interest in cancer biology, imaging and/or radionuclide therapy. You will be have strong experimental skills and will be able to demonstrate ability to design and carry out laboratory studies using a range of biomedical (imaging) techniques. Experience in immunohistochemistry or holding a Home Office personal licence (PIL) will be advantageous.This is a full-time post is available for 3 years in the first instance.All applicants must complete a short application form and upload a CV and supporting statement. To apply for this role, please click on the ‘Apply Now’ button in the link below.The closing date for applications is 12.00 noon on 27 April 2017.
Thursday, April 27, 2017 - 12:00
CRUK/MRC Oxford Institute for Radiation and Oncology
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.